Back to results
US 2014/0271654 A1Published application
Methods for treating bone gap defects
AssigneeAmgen Inc.
InventorsXiaodong Li, Hua Zhu Ke
Life of this patent
Estimating the term…
Abstract
The invention provides a method of enhancing bone gap defect healing involving administering a sclerostin inhibitor.
Claims22
A method for treating a bone gap defect in a subject comprising administering to the subject an effective amount of an anti-sclerostin antibody, optionally at a weekly dose from about 1 mg/kg to about 50 mg/kg per week, wherein the anti-sclerostin antibody is administered over a treatment period lasting at least 20 weeks.
(canceled)
22-24. (canceled)
Dependencies are inferred from the claim text.